ArticleScientific reports2025
Diagnostic value of magnetic controlled capsule endoscopy in patients with chronic abdominal pain: a retrospective two-center study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Magnetic controlled capsule endoscopy (MCE) overcomes limitations of capsule endoscopy and achieves one-time gastro-small intestinal joint examination. However, few studies have reported diagnostic value of MCE of gastrointestinal lesions in patients with abdominal pain. This study aims to investigate clinical applications of MCE in patients with abdominal pain. 465 patients suffered chronic abdominal pain and 366 asymptomatic subjects from two hospitals were included. Patient characteristics, MCE findings, incomplete examinations, examination time and adverse events were evaluated. In the abdominal pain group, disease spectrum was more diverse covering 45 types gastrointestinal lesions. Gastric lesions including atrophic gastritis, erosion, ulcer, carditis, polyp and submucosal tumor, and small intestinal lesions including lymphangiectasia, erosion, ulcer, angiotelectasis, bleeding and Crohn's disease, had the higher detection rates (all P < 0.05). Some patients detected small intestinal lesions accompanied by diarrhea, weight loss and hematochezia. The abdominal pain group had the lower completion rate and longer transit time (all P < 0.05). In conclusion, MCE is beneficial to detect diverse disease spectrum and atrophic gastritis, ulcer, erosion, Crohn's disease and small intestinal bleeding in patients with abdominal pain, and to find more lesions as one-time gastro-small intestine joint examination, with efficiency, safety, noninvasiveness and high completion rate.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.